Molecular mechanism of cell cycle arrest caused by diallyl trisulfide (DATS), a garlic-derived cancer chemopreventive agent, has been investigated using PC-3 and DU145 human prostate cancer cells as a model. Treatment of PC-3 and DU145 cells, but not a normal prostate epithelial cell line (PrEC), with growth suppressive concentrations of DATS caused enrichment of the G 2 -M fraction. The DATS-induced cell cycle arrest in PC-3 cells was associated with increased Tyr 15 phosphorylation of cyclin-dependent kinase 1 (Cdk1) and inhibition of Cdk1/cyclinB1 kinase activity. The DATStreated PC-3 and DU145 cells also exhibited a decrease in the protein level of Cdc25C and an increase in its Ser 216 phosphorylation. The DATS-mediated decrease in protein level and Ser 216 phosphorylation of Cdc25C as well as G 2 -M phase cell cycle arrest were significantly attenuated in the presence of N-acetylcysteine implicating reactive oxygen species (ROS) in cell cycle arrest caused by DATS. ROS generation was observed in DATS-treated PC-3 and DU145 cells. DATS treatment also caused an increase in the protein level of Cdk inhibitor p21, but DATS-induced G 2 -M phase arrest was not affected by antisense-mediated suppression of p21 protein level. In conclusion, the results of the present study indicate that DATS-induced G 2 -M phase cell cycle arrest in human prostate cancer cells is caused by ROS-mediated destruction and hyperphosphorylation of Cdc25C.
Introduction
Medicinal benefits of Allium vegetables, such as garlic and onions, are well documented and include cholesterol lowering and anticancer effects (Dausch and Nixon, 1990; Agarwal, 1996) . Epidemiological studies have concluded that dietary intake of Allium vegetables may reduce the risk of various types of malignancies including cancer of the prostate (You et al., 1989; Challier et al., 1998; Gao et al., 1999; Hsing et al., 2002) . For example, the risk of prostate cancer was suggested to be significantly lower in men consuming >10 g/day of total Allium vegetables than in men with low total Allium vegetable intake (o2.2 g/day) (Hsing et al., 2002) . Laboratory studies indicate that anticarcinogenic effect of Allium vegetables is due to organosulfur compounds (OSCs), which are generated upon processing (e.g., cutting or chewing) of these vegetables (Block, 1992; Milner, 2001) .
Garlic-derived OSCs including diallyl sulfide (DAS), diallyl disulfide (DADS) and diallyl trisulfide (DATS) have been shown to offer significant protection against cancer in animal models induced by a variety of chemical carcinogens (Wargovich, 1987; Sparnins et al., 1988; Wargovich et al., 1988; Wattenberg et al., 1989; Sumiyoshi and Wargovich, 1990; Takahashi et al., 1992; Reddy et al., 1993; Schaffer et al., 1996; Suzui et al., 1997) . For example, cancer chemoprevention by naturally occurring OSC analogues has been observed against benzo [a] pyrene-induced forestomach and pulmonary carcinogenesis in mice (Sparnins et al., 1988) , N-nitrosomethylbenzylamine-induced esophageal cancer in rats (Wargovich et al., 1988) , and 1,2-dimethylhydrazine-induced colon cancer in mice (Sumiyoshi and Wargovich, 1990) .
More recent studies including those from our laboratory have revealed that some naturally occurring OSC analogues can inhibit proliferation of cultured cancer cells by causing apoptosis and/or cell cycle arrest (Sundaram and Milner, 1996; Milner, 1998, 2000; Nakagawa et al., 2001; Robert et al., 2001; Shirin et al., 2001; Kwon et al., 2002; Li and Lu, 2002; Filomeni et al., 2003; Xiao et al., 2003; Lan and Lu, 2004; Xiao et al., 2004 ). Milner and co-workers were the first to report apoptosis induction and cell cycle arrest by DADS in human colon cancer cells (Sundaram and Milner, 1996; Milner, 1998, 2000) . The DADS-induced apoptosis in colon cancer cells correlated positively with an increase in the level of intracellular free calcium (Sundaram and Milner, 1996) . In MDA-MB-231 human breast cancer cell line, the DADS-induced apoptosis was associated with upregulation of Bax, downregulation of Bcl-X L and activation of caspase-3 (Nakagawa et al., 2001) . The DATS-induced apoptosis in BGC823 human gastric cancer cell line was associated with downregulation of Bcl-2 and activation of caspase-3 (Lan and Lu, 2004) . Even though considerable progress has been made towards our understanding of the signaling pathways responsible for OSC-induced apoptosis (reviewed in Herman-Antosiewicz and , the mechanism of cell cycle arrest caused by OSC analogues is not fully understood.
The present study was undertaken to gain insights into the mechanism by which DATS inhibits cell cycle progression using prostate cancer cells as a model. We demonstrate that DATS-induced cell cycle arrest in prostate cancer cells is caused by generation of reactive oxygen species (ROS), but independent of p21.
Results

DATS treatment caused G 2 -M phase cell cycle arrest in PC-3 cells
Figure 1 depicts representative histograms for cell cycle distribution in PC-3 cells following a 24 h exposure to dimethyl sulfoxide (DMSO) or 40 mM DATS, DADS or DAS. As can be seen in Table 1 , a 24 h exposure of PC-3 cells to growth suppressive concentrations of DATS (20 and 40 mM) resulted in a statistically significant increase in G 2 -M fraction that was accompanied by a decrease in G 0 /G 1 and S phase cells. For example, the percentage of G 2 -M fraction was increased by about 1.8-and 2.8-fold on treatment of PC-3 cells with 20 and 40 mM DATS, respectively, when compared with DMSO-treated control (Table 1) . On the other hand, neither DAS nor DADS treatment had any appreciable effect on G 2 -M cells (Table 1, Figure 1 ). In time course experiments using 20 and 40 mM DATS, the G 2 -M phase cell cycle arrest was evident as early as 4 h after treatment, and persisted for the duration of the experiment (Figure 2 ). These results indicated that the inhibitory effect of DATS against proliferation of PC-3 cells correlated with G 2 -M phase cell cycle arrest.
Next, we raised a question whether DATS-mediated inhibition of PC-3 cell viability and cell cycle progression was selective for cancer cells, which is a highly desirable feature of potential chemopreventive agents. We addressed this question by determining the effect of DATS treatment on viability and cell cycle distribution of a normal prostate epithelial cell line (PrEC), and the results are shown in Figure 3 . The PrEC cell line has been used extensively as a representative normal prostate epithelial cell line (Campbell et al., 1999; Chen et al., 2001; Garraway et al., 2003) . Proliferating PrEC cells exhibit several features most consistent with the prostate epithelial origin, such as immunostaining for cytokeratin 8 and weak expression of PSA (Campbell et al., 1999) . The viability of PrEC cells, assessed by trypan blue dye exclusion assay, was not significantly affected by DATS treatment even at concentrations (e.g. 40 and 80 mM) that were highly cytotoxic to the PC-3 cell line ( Figure 3a) . The sulforhodamine B assay confirmed that the PrEC cell line was significantly more resistant to cell killing by DATS compared with PC-3 cells (Figure 3b ). In agreement with these results, DATS treatment did not alter cell cycle distribution in PrEC cultures even at 40 mM (Figure 3c ), a concentration that caused statistically significant enrichment of the G 2 -M fraction in PC-3 cells (Figure 1 , Table 1 ). These results indicated that PrEC was resistant to cell cycle arrest by DATS.
Effect of DATS treatment on G 2 -M regulators
Eukaryotic cell cycle progression involves sequential activation of cyclin-dependent kinases (Cdks), whose activity is dependent upon their association with regulatory cyclins (Molinari, 2000; Taylor and Stark, 2001) . A complex between Cdk1 and cyclinB1 is important for entry into mitosis in most organisms (Molinari, 2000; Taylor and Stark, 2001 ). The activity of Cdk1/cyclinB1 kinase is negatively regulated by reversible phosphorylations at Thr 14 and Tyr 15 of Cdk1 (Molinari, 2000; Taylor and Stark, 2001 ). Dephosphorylation of Thr 14 and Tyr 15 of Cdk1, and hence activation of Cdk1/cyclinB1 kinase complex, is catalysed by the Cdc25 dual specificity phosphatases, and this reaction is believed to be a rate-limiting step for entry into mitosis (Draetta and Eckstein, 1997) . We determined the effect of DATS treatment on levels of Cdk1, cyclinB1, Cdc25B and Cdc25C proteins by immunoblotting to gain insights into the mechanism of cell cycle arrest in our model. Lysates from DAS-and DADS-treated cells were included as controls since these OSC analogues did not affect cell cycle distribution. As can be seen in Figure 4a , treatment of PC-3 cells with DATS, but not DAS or DADS, resulted in an increase in the protein level of cyclinB1 at 16-24 h time points. The level of Cdk1 protein was not altered by DAS or DADS, but a decrease in the level of this protein was observed in DATS-treated PC-3 cells at 16 and 24 h time points. None of the OSC analogues affected the level of Cdc25B protein (data not shown). On the other hand, exposure of PC-3 cells to DATS, but not DAS or DADS, resulted in a decrease in the protein level of Cdc25C, which was accompanied by appearance of a band with reduced electrophoretic mobility. The slower migrating band did not fully account for the loss of the Cdc25C protein as judged by densitometric scanning of the doublets and the triplets (Figure 4a ). The DATS-mediated decrease in Cdc25C protein level was observed as early as 4 h after treatment, and persisted for the duration of the experiment. These results suggested that the DATSinduced cell cycle arrest in PC-3 cells was caused, at least in part, by changes in the Cdc25C.
DATS treatment increased Ser 216 phosphorylation of Cdc25C
Immunoblotting for Cdc25C consistently showed an immunoreactive band with reduced electrophoretic mobility in DATS-treated lysate, which was not observed in vehicle-treated control ( Figure 4a ). Electrophoretic mobility retardation of a protein is often indicative of its post-translation modification such as phosphorylation. To determine if the band with reduced electrophoretic mobility represented phosphorylated form of Cdc25C, we pretreated the lysates from control (DMSO-treated) and DATS-treated cells with l protein phosphatase prior to immunoblotting for Cdc25C. The reduced electrophoretic mobility band was not observed if the DATS-treated lysate was treated with l protein phosphatase prior to electrophoresis and immunoblotting (results not shown). These results indicated that the slower migrating band indeed represented phosphorylated form of Cdc25C.
Cdc25C is known to be phosphorylated at Ser
216
, and this post-translational modification creates a binding site for 14-3-3 proteins, which sequester Cdc25C in the cytoplasm (Peng et al., 1997; Sanchez et al., 1997) . We therefore performed immunoblotting to determine if DATS treatment promoted Ser 216 phosphorylation of Cdc25C. As can be seen in Figure 4b , the level of Ser 216 -phosphorylated Cdc25C was markedly higher in the lysates of DATS-treated PC-3 cells compared with control. To determine the functional significance of Cdc25C phosphorylation, we immunoprecipitated 14-3-3b from the lysates of control and DATS-treated cells, and the immunoprecipitated complexes were then subjected to immunoblotting using anti-Cdc25C antibody. As shown in Figure 4c , DATS treatment resulted in increased binding of Cdc25C with 14-3-3b. These results indicated that DATS treatment caused an increase in Ser 216 phosphorylation of Cdc25C and promoted its binding with 14-3-3b, which could lead to cytoplasmic sequestration of Cdc25C. We attempted to confirm cytoplasmic sequestration of Cdc25C in DATS-treated PC-3 cells by immunohistochemistry, but the results of these studies were inconclusive (results not shown) mainly because of low signal intensity due to DATS-mediated decrease in the protein level of Cdc25C.
DATS treatment inhibited activity of Cdk1/cyclinB1 kinase
Since Cdc25C has an important role in activating Cdk1/ cyclinB1 kinase, we reasoned that the DATS-mediated hyperphosphorylation and decrease in the protein level of Cdc25C may cause accumulation of Tyr 15 -phosphorylated (inactive) Cdk1. Indeed, the immunoblotting confirmed an increase in the level of Tyr 15 -phosphorylated Cdk1 in DATS-treated PC-3 cells compared with vehicle-treated control (Figure 5a ). In agreement with these results, the kinase activity of Cdk1/cyclinB1 complex was approximately 40-45% lower in DATStreated PC-3 cells compared with control ( Figure 5b ). These results indicated that the cell cycle arrest on treatment of PC-3 cells with DATS was due to inhibition of Cdk1/cyclinB1 kinase activity.
Next, we determined the effect of DATS treatment on cell morphology by immunohistochemistry following staining with anti-a-tubulin antibody and 4 0 ,6-diamidino-2-phenylindole dihydrochloride (DAPI), and the results are shown in Figure 5c . The vehicle-treated control PC-3 cells generally exhibited an intact microtubule network as revealed by a-tubulin immunostaining (red staining), whereas the a-tubulin staining in a large fraction of DATS-treated cells was restricted to the periphery of the nucleus (Figure 5c ). In addition, the DATS-treated PC-3 cells exhibited DNA fragmentation (identified by arrows in the right-hand panel of Figure 5c ) as well as membrane blebbing (identified by an arrow in the middle panel of Figure 5c ), which are characteristic features of cells undergoing apoptosis. These results confirm our previous observations that DATS treatment causes apoptotic cell death in PC-3 cells (Xiao et al., 2004) .
DATS-induced G 2 -M phase cell cycle arrest was linked to ROS generation
It has been shown previously that exposure of HeLa cells to H 2 O 2 causes destruction of Cdc25C protein but not the Cdc25A isoform (Savitsky and Finkel, 2002) . On the other hand, Cdc25A protein under certain stresses (e.g. exposure to UV light or DNA synthesis inhibitors) is degraded through a checkpoint kinase-dependent pathway (Mailand et al., 2000; Molinari et al., 2000; Falck et al., 2001) . As the cell cycle arrest in DATStreated PC-3 cells was associated with a decrease in the protein level of Cdc25C (Figure 4a ), we hypothesized that its degradation in our model may be caused by ROS generation. We tested this hypothesis by monitoring ROS generation in DATS-treated PC-3 cells. Intracellular ROS generation in control (DMSO-treated) and DATS-treated cells was assessed by flow cytometry following staining with hydroethidine (HE) and 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H 2 DCFDA), which are somewhat specific for detection of O 2 À Á and H 2 O 2 , respectively (Rothe and Valet, 1990; Narayanan et al., 1997) . In the presence of O 2 À Á , HE is oxidized to ethidium bromide that can be detected by flow cytometry using a 585-nm bandpass filter, whereas H 2 DCFDA is oxidized in the presence of H 2 O 2 and peroxidases to yield fluorescent 2 0 ,7 0 -dichlorofluorescein (DCF) that can be detected using a 530-nm bandpass filter. Representative histograms depicting ethidium bromide and DCF fluorescence following a 4 h treatment of PC-3 cells with DMSO (control) and 40 mM DATS are shown in Figure 6a . The DATS-treated PC-3 cells exhibited a statistically significant increase in both ethidium bromide ( Figure 6b ) and DCF fluorescence ( Figure 6c ) compared with control at both 4 and 8 h time points. These results indicated that DATS treatment caused ROS production in PC-3 cells.
To further examine the association of ROS generation with cell cycle arrest, we exposed PC-3 cells to DATS in the absence or presence of NAC, a known antioxidant, prior to analysis of cell cycle distribution. As can be seen in Figure 7a , the G 2 -M phase cell cycle arrest was observed in DATS-treated (40 mM, 8 h) PC-3 cells when compared with DMSO-treated controls. On the other hand, the G 2 -M phase arrest was not observed in PC-3 cultures cotreated with NAC and DATS. The NAC treatment alone did not affect cell cycle distribution in PC-3 cells. Furthermore, the DATS-mediated decrease in the protein level as well as Ser 216 phosphorylation of Cdc25C was also attenuated in the presence of NAC (Figure 7b ). NAC treatment alone did not affect the protein level or phosphorylation of Cdc25C. These results indicated that DATS-mediated decrease in the protein level and phosphorylation of Cdc25C was likely initiated by ROS.
Effect of DATS treatment on Cdc25C protein level and cell cycle distribution in DU145 cells
Next, we raised the question whether the positive correlation between DATS-mediated degradation of Cdc25C and cell cycle arrest observed in PC-3 was restricted to this cell line due to its unique characteristics. We addressed this question by determining the effect of DATS treatment on cell cycle distribution as well as Cdc25C protein level using DU145 prostate adenocarcinoma cells. As can be seen in Figure 8a , treatment of DU145 cells with 20 and 40 mM DATS resulted in an approximate 1.9-and 4.3-fold increase in G 2 -M fraction, respectively, when compared with control. In addition, immunoblotting using lysates from DATS-treated DU145 cells revealed a marked decrease in the protein level of Cdc25C (Figure 8b, upper panel) , which was relatively more pronounced in this cell line compared with PC-3. It is not surprising that the DATSinduced G 2 -M phase cell cycle arrest was also relatively more pronounced in DU145 cells (Figure 8a ) compared with PC-3 (Table 1) The association between DATS-induced ROS generation and cell cycle arrest was also investigated using DU145 cells, and the results are shown in Figure 9 . Similar to PC-3 cells, exposure of DU145 cells to DATS resulted in a statistically significant increase in ethidium bromide (Figure 9a ) as well as DCF fluorescence (Figure 9b ) at 4 h time point. Furthermore, the DATSinduced G 2 -M phase cell cycle arrest in DU145 cells was also attenuated in the presence of NAC (Figure 9c) . Collectively, these results indicated that the positive correlation between DATS-mediated ROS generation and cell cycle arrest is not unique to the PC-3 cell line.
Role of p21 DATS-induced cell cycle arrest
The p21 waf1/cip1 (hereafter referred to as p21) protein is best known for its role as a regulator of the G 1 /S transition (Harper et al., 1993) , but accumulating evidence suggest that this protein may also regulate DNA damage-induced G 2 arrest (Bunz et al., 1998; Dulic et al., 1998; Winters et al., 1998; CharrierSavournin et al., 2004) . Since induction of p21 mRNA and protein expression in DADS-treated colon carcinoma cells was demonstrated recently (Druesne et al., 2004) , we explored the role of p21, if any, in cell cycle arrest caused by DATS. Initially, we determined the effect of DATS treatment on p21 protein level by immunoblotting using PC-3 cells, and the results are shown in Figure 10a . Immunoblotting revealed a markedly higher level of p21 protein (up to 10-fold higher compared with control) in the lysates of DATStreated PC-3 cells compared with control ( Figure 10a ). Induction of p21 protein on treatment with DATS was evident as early as 1 h after treatment, peaked between 4 and 16 h, and declined thereafter ( Figure 10a ). Next, we determined the effect of p21 protein knockdown, through stable transfection of PC-3 cells with a p21 antisense, on cell cycle arrest caused by DATS. Several transfectants were screened for protein level of p21, and one clone designated as p21AS-n3 exhibiting a near complete loss of p21 protein was used for functional studies. A representative immunoblot for p21 protein using lysates from vector-transfected control PC-3 cells and p21AS-n3 cells following 8 h treatment with DMSO or 40 mM DATS is shown in Figure 10b . Similar to untransfected PC-3 cells, the level of p21 protein was increased on treatment of vector-transfected control PC-3 cells with DATS. The expression of p21 protein could not be detected in p21AS-n3 cells even after treatment with DATS. These results indicated that the expression of p21 protein was silenced in p21AS-n3 cells. The effect of DATS treatment (40 mM, 8 h) on cell cycle distribution was determined using vector-transfected control PC-3 cells and p21AS-n3 cells, and the results are shown in Figure 10c . Similar to untransfected PC-3 cells (Figure 1) , DATS treatment caused enrichment of G 2 -M fraction in vector-transfected control PC-3 cells (Figure 10c, bottom panel) . The G 2 -M phase cell cycle arrest on treatment with DATS was also evident in p21AS-n3 cells (compare bottom panel in Figure 10c ). These results argued against involvement of p21 protein in DATS-induced cell cycle arrest, at least in the PC-3 cell line.
Discussion
We have shown previously that DATS treatment causes apoptosis in both PC-3 and DU145 cells as judged by TUNEL assay and analysis of cytoplasmic histoneassociated DNA fragmentation and flow cytometric detection of subdiploid cells (Xiao et al., 2004) . The DATS-induced apoptosis in prostate cancer cells is associated with a decrease in the protein level of Bcl-2 as well as c-Jun N-terminal kinase-mediated, and to some extent extracellular signal-regulated kinase-mediated, phosphorylation of Bcl-2 leading to reduced interaction between Bcl-2 and Bax (Xiao et al., 2004) . We also found that ectopic expression of Bcl-2 in PC-3 cells confers significant protection against the cell death caused by DATS (Xiao et al., 2004) . Apoptosis induction by DATS has also been observed in BGC823 human gastric cancer cell line, as judged by analysis of cell morphology, appearance of subdiploid cells and DNA fragmentation (Li and Lu, 2002; Lan and Lu, 2004) . Similar to our data in PC-3 cells (Xiao et al., 2004) , the DATS-treated BGC823 cells exhibited a marked decrease in the protein level of Bcl-2 and activation of caspase-3 (Lan and Lu, 2004) . Thus, it is reasonable to conclude that DATS targets Bcl-2 to trigger the cell death in cancer cells. Using a modified cDNA representational difference analysis, Li and Lu (2002) identified 14 differentially expressed genes (11 genes upregulated and three genes downregulated) in DATS-treated BGC823 cells. However, further studies are needed to determine whether these differentially expressed genes contribute to DATS-induced apoptosis or cell cycle arrest.
The present study indicates that DATS treatment inhibits G 2 -M progression in human prostate cancer cells. On the other hand, PrEC is highly resistant to growth inhibition as well as cell cycle arrest by DATS (Figure 3 ) even at concentrations that are highly cytotoxic to the prostate cancer cells. These results suggest that DATS may selectively target cancer cells but spare normal cells, which is a highly desirable property of potential cancer preventive and therapeutic agents. It is interesting to note that neither DAS nor DADS cause cell cycle arrest in PC-3 (Table 1 and Figure 1 ), which was unexpected because previous work by Milner and co-workers demonstrated a G 2 -M phase cell cycle arrest in colon cancer cells following treatment with 25 and 50 mM DADS (Knowles and Milner, 1998) . Although the reasons for this discrepancy are not clear, it is possible that DADS-induced G 2 -M arrest is unique to colon cancer cells. This possibility is substantiated by the findings of Vogt et al. (2000) who failed to observe a G 2 -M phase cell cycle arrest in MCF-7 human breast cancer cells even after treatment with 50 mM DADS for 48 h. At the same time, the possibility that DADS concentrations higher than 40 mM might be required to observe cell cycle arrest in prostate cancer cells cannot be ruled out. Nonetheless, it is clear that the oligosulfide chain length has a profound impact on biological activity of OSCs because DATS is relatively more effective than either DAS or DADS in inhibiting proliferation of prostate cancer cells (Xiao et al., 2004) . However, it remains to be determined whether this structure-activity relationship is unique to the prostate cancer cells or applicable to other types of cancer cells. The DATS-mediated inhibition of G 2 -M progression in both PC-3 and DU145 cells is associated with a decrease in the protein level of Cdc25C as well as its hyperphosphorylation at Ser 216 (Figures 4a and 8b ). Phosphorylation of Cdc25C at Ser 216 , which causes retention of Cdc25C in the cytoplasm due to increased binding with 14-3-3 (Peng et al., 1997; Sanchez et al., 1997) , has been documented in response to DNA damage. Several kinases including Chk1 and Chk2 have been implicated in Ser 216 phosphorylation of Cdc25C (Sanchez et al., 1997; Furnari et al., 1997; Matsuoka et al., 1998; Peng et al., 1998) . Even though further studies are needed to identify the kinases responsible for DATS-induced phosphorylation of Cdc25C in PC-3/ DU145 cells, the cell cycle arrest in our model is indeed associated with increased binding of Cdc25C with 14-3-3b as revealed by immunoprecipitation-immunoblotting experiment (Figure 4c ). We attempted to confirm cytoplasmic sequestration of Cdc25C in DATS-treated PC-3 cells by immunohistochemistry (results not shown). However, the results of these studies were inconclusive because of weak Cdc25C signal intensity due to DATS-mediated degradation of this protein.
Nonetheless, the present study indicates that DATSinduced cell cycle arrest in prostate cancer cells is caused by a reduction in kinase activity of Cdk1/cyclinB1 resulting from degradation as well as hyperphosphorylation of Cdc25C.
The Cdk1/cyclinB1 kinase complex is considered a master regulator of G 2 -M progression (Molinari, 2000; Taylor and Stark, 2001 ). In addition to reversible phosphorylations at Thr 14 and Tyr 15 of Cdk1, the activity of Cdk1/cyclinB1 kinase is also dependent upon complex formation between Cdk1 and cyclinB1 (Molinari, 2000; Taylor and Stark, 2001) . Even though the level of Cdk1 protein is reduced by about 50% compared with control on treatment of PC-3 cells with DATS for 24 h (Figure 4a ), we believe that the cell cycle arrest in our model is probably not caused by a reduction in the level of Cdk1/cyclinB1 complex, because DATS-mediated decrease in Cdk1 protein level is observed after onset of cell cycle arrest. The present study also indicates that despite induction of p21 protein in DATS-treated cells, this Cdk inhibitor does not contribute to the cell cycle arrest in our model.
It is interesting to note that DATS-treated cells exhibit an increase in the level of cyclinB1 (Figure 4a ), which has also been observed in DADS-treated HCT-15 cells (Knowles and Milner, 2000) . In cycling cells, the level of cyclinB1 protein increases abruptly during late S-early G 2 , peaks during the metaphase/anaphase transition, and declines precipitously upon completion of mitosis (Pines and Hunter, 1991; Sherwood et al., 1994; Widrow et al., 1997) . Degradation of cyclinB1 is necessary for mitotic exit (Sherwood et al., 1994; Widrow et al., 1997) . As DATS treatment causes accumulation of cyclinB1, it is possible that the DATS-treated cells may not be able to exit mitosis. Preliminary studies from our laboratory indicate that DATS treatment indeed arrests PC-3 cells in mitosis (Herman-Antosiewicz A and Singh SV, unpublished observations). Studies are in progress to define the mechanism of DATS-mediated mitotic arrest.
The present study indicates, for the first time, that the DATS-mediated degradation as well as Ser 216 phosphorylation of Cdc25C in prostate cancer cells is initiated by ROS generation. This conclusion is based on the following observations: (a) DATS treatment causes ROS generation in both PC-3 and DU145 cells, (b) the DATS-induced degradation as well as Ser 216 phosphorylation of Cdc25C is attenuated in the presence of NAC, (c) the cell cycle arrest caused by DATS is also abolished on cotreatment with NAC and (d) there is a good correlation between DATS-mediated ROS generation and the extent of G 2 /M block; the DU145 cell line being relatively more sensitive to ROS generation as well as cell cycle arrest compared with PC-3 cells. However, the precise mechanism by which DATS treatment causes ROS generation remains to be elucidated.
The DATS-induced cell cycle arrest in prostate cancer cells was observed at 20-40 mM concentrations. It is unclear if such concentrations of DATS are achievable in humans because of lack of pharmacokinetic data on this agent. However, the pharmacokinetics of S-allylcysteine, a water soluble OSC analog, has been studied in rodents and dogs (Nagae et al., 1994) . This study showed that S-allylcysteine was absorbed rapidly, and reached peak plasma concentration within 0.5-1 h. The plasma concentrations following oral administration of 12.5, 25 and 50 mg S-allylcysteine/kg body weight were about 50, 112 and 227 mM, respectively (Nagae et al., 1994) . Thus, it is possible that the concentrations of DATS required to inhibit cell proliferation and cause cell cycle arrest and apoptosis may be achievable in humans.
Materials and methods
Reagents
DAS and DADS ware purchased from Aldrich (Milwaukee, WI, USA), whereas DATS was procured from LKT Labora- 
Cell culture and cell cycle analysis
Monolayer cultures of PC-3 and DU145 cells were maintained as described by us previously (Xiao et al., 2004) . Both cell lines are positive for cytokeratin 8 and cytokeratin 18 and negative for desmin confirming their epithelial origin (Webber et al., 1997a; Mitchell et al., 2000) . The PC-3 cell line lacks p53 whereas the DU145 cell line expresses mutant p53 (Webber et al., 1997b) . Both cell lines are considered androgen unresponsive but respond differentially to exogenous growth factors (Webber et al., 1997a) . For example, both cell lines produce measurable amounts of bFGF but only DU145 cells respond to growth stimulation by exogenous bFGF (Nakamoto et al., 1992) . The PC-3 cells express apparently normal Rb protein, whereas the DU145 cell line has a mutated Rb gene encoding a truncated protein (Bookstein et al., 1990) . Normal prostate epithelial cell line PrEC (Clonetics, San Diego, CA, USA) was maintained in PrEBM (Cambrex, Rockland, ME, USA). Each cell line was maintained in a humidified atmosphere of 95% air and 5% CO 2 at 371C. The effect of DATS on viability of PrEC was determined by trypan blue dye exclusion and sulforhodamine B assays as described by us previously (Xiao et al., 2004) . The effect of DAS, DADS or DATS on cell cycle distribution was determined by flow cytometry following staining with propidium iodide as described previously . Briefly, PC-3, DU145 or PrEC cells (5 Â 10 5 ) were seeded in T25 flasks, and allowed to attach by overnight incubation. The medium was replaced with fresh complete medium containing desired concentrations of DAS, DADS or DATS. Stock solutions of DAS, DADS and DATS were prepared in DMSO, and an equal volume of DMSO (final concentration 0.05%) was added to the controls. After incubation at 371C for the desired time point, floating and adherent cells were collected, washed with phosphate-buffered saline (PBS), and fixed with 70% ethanol. The cells were then treated with RNaseA and propidium iodide as described previously .
Immunoblotting
Cells were treated with the desired OSC or DMSO as described above, and lysed as described by us previously (Xiao and Singh, 2002; Singh et al., 2004; Choi and Singh, 2005) . The cell lysates were cleared by centrifugation at 14 000 r.p.m. for 15 min. The proteins were resolved by sodium-dodecyl sulfatepolyacrylamide gel electrophoresis, and transferred onto PVDF membrane. After blocking with 5% nonfat dry milk solution in Tris-buffered saline containing 0.2% Tween-20, the membrane was incubated with the desired primary antibody for 1 h. The membrane was then treated with appropriate secondary antibody, and the immunoreactive bands were visualized using enhanced chemiluminescence method. Each membrane was stripped and reprobed with anti-actin antibody to correct for differences in protein loading. Immunoblotting for each protein was performed at least twice using independently prepared lysates, and the results were similar. In some experiments, the cells were treated with DATS in the absence or presence of NAC prior to the preparation of cell lysates and immunoblotting.
l Protein phosphatase treatment
In vitro l protein phosphatase treatment was performed according to the protocol provided by the manufacturer (New England Biolabs). Briefly, 40 mg of lysate protein from cells exposed for 24 h to 40 mM DATS or DMSO (control) was incubated with either l protein phosphatase (400 U) or the control buffer at 301C for 4 h prior to immunoblotting for Cdc25C.
Immunoprecipitation
PC-3 cells were treated with DMSO or 40 mM DATS for 4 or 24 h, washed twice with ice-cold PBS, and lysed as described above. Aliquot containing 500 mg of lysate protein was incubated overnight at 41C with 10 mg of anti-14-3-3b antibody. Protein A-agarose (50 ml, Santa Cruz) was subsequently added to each sample, and the incubation was continued for an additional 3 h at 41C with gentle shaking. The immunoprecipitates were subjected to sodium-dodecyl sulfate polyacrylamide gel electrophoresis followed by immunoblotting using anti-Cdc25C antibody.
Cdk1/cyclinB1 kinase assay
Control and DATS-treated PC-3 cells were collected, and lysed using a solution containing 50 mM Tris-HCl (pH 7.5), 1% Triton X-100, 150 mM NaCl, 0.5 mM EDTA and protease and phosphatase inhibitor cocktails. Lysate proteins (300 mg) were incubated overnight at 41C with 2 mg of Cdk1-agarose beads (Santa Cruz, cat. #sc-54 AC). The kinase activity of the immunoprecipitated Cdk1 was determined using a kit from Upstate Biotechnology (Lake Placid, NY, USA) according to the manufacturer's recommendations.
Immunohistochemistry
PC-3 cells (2 Â 10 5 ) were grown on coverslips, and allowed to attach overnight. The cells were then exposed to DMSO or 40 mM DATS for the indicated time periods, washed with PBS, and fixed with 2% paraformaldehyde overnight at 41C. Subsequently, the cells were permeabilized with 0.1% Triton-X100 for 15 min at room temperature, washed with PBS, and incubated with normal goat serum [1 : 20 dilution in PBS containing 0.5% (w/v) bovine serum albumin and 0.15% (w/v) glycine (BSA buffer)] for 45 min at room temperature. After washing with BSA buffer, cells were treated with anti-a-tubulin (1 : 4000 dilution; Sigma, cat. #T-5168) antibody for 1 h at room temperature. After washing with BSA buffer, the cells were treated with 1 mg/ml Alexa Fluor 568-conjugated goat anti-mouse antibody (Molecular Probes, cat. #A-11004) for 1 h at room temperature. The cells were then treated with 10 ng/ml DAPI. Slides were mounted and examined under a Leica fluorescence microscope at Â 100 magnification (objective lenses).
Measurement of ROS generation
Intracellular ROS generation was measured by flow cytometry following staining with HE and H 2 DCFDA, which have been shown to be relatively specific for detection of O 2 À Á and H 2 O 2 , respectively (Rothe and Valet, 1990; Narayanan et al., 1997) . Cells (5 Â 10 5 ) were plated in 60-mm dishes, allowed to attach overnight, and exposed to DATS (40 mM) for specified time intervals. The cells were stained with 2 mM HE and 5 mM H 2 DCFDA for 30 min at 371C. Cells were collected, and the fluorescence was analysed using a Flow Cytometer.
Antisense transfection
PC-3 cells were stably transfected with a p21 antisense construct, kindly provided by Dr S Grant (Freemerman et al., 1997) or empty pREP4 vector (Invitrogen, Carlsbad, CA, USA) using Lipofectamine (Invitrogen). Clones resistant to hygromycin B (300 mg/ml) were screened for p21 expression by immunoblotting. One of the clones designed as p21AS-n3 and the cells carrying the empty vector were used in subsequent experiments to determine the effect of DATS treatment on cell cycle distribution.
Statistical analysis
Statistical significance of difference in measured variables between control and treated groups was determined by paired t-test or one-way ANOVA followed by Dunnett's or Bonferroni's multiple comparison tests. Statistical significance was determined at the 0.05 level.
